Literature DB >> 10653923

Dyslipidemia and coronary artery disease.

J G Genest1.   

Abstract

Atherosclerotic vascular diseases are expected to remain the major cause of mortality and morbidity globally well into the 21st century. Preventive measures by lifestyle changes (diet, exercise, smoking cessation, prevention of obesity and diabetes) will play an important role in retarding the onset of these diseases. A strategy aimed at identifying high risk individuals - those with established coronary artery disease or other vascular diseases - will provide the most cost effective means of preventing cardiovascular events. The high risk strategy is aimed at identification of healthy subjects with multiple cardiovascular risk factors, identification of those with diabetes, identification of those with genetic lipoprotein disorders and initiation of treatment with medications if necessary. Categorical risk factors should be treated because of the lifetime increase in cardiovascular risk.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10653923

Source DB:  PubMed          Journal:  Can J Cardiol        ISSN: 0828-282X            Impact factor:   5.223


  5 in total

1.  Efficacy and safety of statins in hypercholesterolemia with emphasis on lipoproteins.

Authors:  San-Chiang Wu; Jeng-Chuan Shiang; Shoa-Lin Lin; Te-Lang Wu; Wei-Chun Huang; Kuan-Rau Chiou; Chun-Peng Liu
Journal:  Heart Vessels       Date:  2005-09       Impact factor: 2.037

Review 2.  The association between metabolic syndrome components and the development of atherosclerosis.

Authors:  Anahita Aboonabi; Roselyn Rose' Meyer; Indu Singh
Journal:  J Hum Hypertens       Date:  2019-10-21       Impact factor: 3.012

3.  AMPK activator C24 inhibits hepatic lipogenesis and ameliorates dyslipidemia in HFHC diet-induced animal models.

Authors:  Shui-Mei Sun; Zhi-Fu Xie; Yang-Ming Zhang; Xin-Wen Zhang; Chen-Dong Zhou; Jian-Peng Yin; Yan-Yan Yu; Shi-Chao Cui; Hao-Wen Jiang; Teng-Teng Li; Jia Li; Fa-Jun Nan; Jing-Ya Li
Journal:  Acta Pharmacol Sin       Date:  2020-07-28       Impact factor: 6.150

4.  Study of pattern of dyslipidemia and its correlation with cardiovascular risk factors in patients with proven coronary artery disease.

Authors:  Namita Mahalle; M K Garg; Sadanand S Naik; Mohan V Kulkarni
Journal:  Indian J Endocrinol Metab       Date:  2014-01

Review 5.  Dyslipidemia and rupture risk of intracranial aneurysms-a systematic review.

Authors:  Katja Løvik; Johnny Laupsa-Borge; Nicola Logallo; Christian A Helland
Journal:  Neurosurg Rev       Date:  2021-03-11       Impact factor: 3.042

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.